1-es típusú cukorbetegség: vizsgálatok itt: Németország
27 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and Participants With Type 2 Diabetes
- Where
- Neuss
- Életkor
- 25 év to 69 év
- People
- 121
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07896109 · EU 2026-525819-14-00 - No phaseTaking peopleLong-Term Outcomes of Teplizumab in Routine Clinical Care
- Where
- Hanover
- People
- 1000 worldwide
- Run by
- Sanofi
See details and how to joinNCT07360080 - No phaseTaking peopleReal-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
- Where
- Augsburg, Frankfurt, Hanover, Munich
- People
- 60 worldwide
- Run by
- Sanofi
See details and how to joinNCT07457580 - 3. fázisTaking peopleA Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Where
- Augsburg, Dresden, Hanover, München
- Életkor
- 1 év to 35 év
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00 - 3. fázisTaking peopleA Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Where
- Hanover, Hof, Karlsburg, Ludwigshafen am Rhein, Munich, Oldenburg in Holstein, Sankt Augustin, Ulm
- Életkor
- 1 év to 35 év
- People
- 300 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00 - No phaseTaking peopleRIGHTEST iFree 2 CGM in Pregnant Women With Diabetes Study
- Where
- Ulm
- Életkor
- 18 év and over
- People
- 104
- Run by
- Bionime Corporation
See details and how to joinNCT07889388 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Berlin, Bochum, Bünde, Dresden, Frankfurt am Main, Frankfurt Am Main, Freiburg im Breisgau, Goettingen, Hamburg, Hanover, Homburg, Jerichow, Karlsruhe, Leipzig, Magdeburg, Mainz, München, Munich, Offenbach Am Main, Schwerin, Speyer, Wiesbaden, Zwenkau
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - 4. fázisTaking peopleAnti-viral action against Type 1 diabetes autoimmunity GPPAD-05-AVAnT1A
- Where
- Dresden, Hanover, Munich
- Életkor
- Up to 17 év
- People
- 2365 worldwide
- Run by
- Klinikum rechts der Isar der TU Muenchen AöR
See details and how to join2023-507348-35-00 · EU 2023-507348-35-00 - No phaseTaking peopleChanges in Person-reported Outcomes and Behavior Using the Accu-Chek SmartGuide CGM and Predict App
- Where
- Bad Mergentheim
- Életkor
- 18 év and over
- People
- 89
- Run by
- FIDAM RDC
See details and how to joinNCT07814508 - 3. fázisTaking peopleA Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Where
- Augsburg, Bielefeld, Dresden, Frankfurt, Freiburg im Breisgau, Hanover, Leipzig, Munich, Ulm
- Életkor
- 1 év to 25 év
- People
- 723 worldwide
- Run by
- Sanofi
See details and how to joinNCT07088068 - 2. fázisTaking peopleSAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Where
- Augsburg, Hanover, Munich
- Életkor
- 5 év to 40 év
- People
- 159 worldwide
- Run by
- SAb Biotherapeutics, Inc.
See details and how to joinNCT07187531 · EU 2025-521560-36-00 - 1. fázisTaking peopleA Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes
- Where
- Neuss
- Életkor
- 18 év to 64 év
- People
- 124
- Run by
- Eli Lilly and Company
See details and how to joinNCT06945406 · EU 2024-519151-28-00 - 3. fázisTaking peopleA trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes
- Where
- Bad Oeynhausen, Bochum, Cologne, Dresden, Falkensee, Gera, Hamburg, Köln, Leipzig, Luebeck, Mainz, Mannheim, Muenster, München, Nürnberg, Obertshausen, Oldenburg in Holstein, Stuttgart, Ulm, Wangen im Allgäu, Wuerzburg
- Életkor
- 18 év and over
- People
- 1010 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-524688-19-00 · EU 2025-524688-19-00 - 3. fázisTaking peopleA Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Where
- Dresden
- Életkor
- 18 év to 65 év
- People
- 57 worldwide
- Run by
- Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00 - 3. fázisTaking peopleAMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Where
- Deggingen, Essen, Gelnhausen, Hamburg, Hohenmölsen, Jerichow, Leipzig, Ratingen
- Életkor
- 45 év and over
- People
- 1778 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07797335 - No phaseTaking peopleINNODIA Family & Friends Early-Stage T1D Detection Protocol
- Where
- Greifswald
- Életkor
- 1 év to 45 év
- People
- 30 000 worldwide
- Run by
- INNODIA iVZW
See details and how to joinNCT07118098 - 1. fázisTaking peopleBioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin
- Where
- Neuss
- Életkor
- 18 év to 64 év
- People
- 16
- Run by
- Sam Chun Dang Pharm. Co. Ltd.
See details and how to joinNCT07634770 - 1. fázisTaking peopleA Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity
- Where
- Neuss
- Életkor
- 18 év to 55 év
- People
- 146
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07578584 - No phaseNot yet taking people in NémetországEvaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes
- Where
- Bad Oeynhausen, Hamburg, Rostock
- Életkor
- 18 év and over
- People
- 230 worldwide
- Run by
- Medtronic MiniMed, Inc.
See details and how to joinNCT07401901 - No phaseTaking peopleDisentangling the Effect of Brain Insulin Resistance on Brain Health
- Where
- Ulm
- Életkor
- 50 év to 80 év
- People
- 150 worldwide
- Run by
- Henrik Bo Wiberg Larsson
See details and how to joinNCT07374705 - No phaseTaking peoplePrecision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups
- Where
- Bad Mergentheim, Würzburg
- Életkor
- 18 év to 80 év
- People
- 1809
- Run by
- Forschungsinstitut der Diabetes Akademie Mergentheim
See details and how to joinNCT07212075 - 1. fázisTaking peopleClamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State
- Where
- Neuss
- Életkor
- 18 év to 64 év
- People
- 12
- Run by
- Gan and Lee Pharmaceuticals, USA
See details and how to joinNCT07242664 - 4. fázisTaking peopleAnti-viral Action Against Type 1 Diabetes Autoimmunity
- Where
- Dresden, Hanover, Munich
- Életkor
- 3 hónap to 4 hónap
- People
- 2252 worldwide
- Run by
- Technical University of Munich
See details and how to joinNCT06452654 - No phaseTaking peopleProspective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients
- Where
- Düsseldorf
- Életkor
- 18 év to 69 év
- People
- 2000
- Run by
- German Diabetes Center
See details and how to joinNCT01055093 - No phaseTaking peopleFreder1k-Study - Testing Infants for Type 1 Diabetes Risk
- Where
- Munich
- Életkor
- 1 nap to 6 hét
- People
- 1 000 000
- Run by
- Helmholtz Zentrum München
See details and how to joinNCT03316261